Treace Medical Concepts, Inc. cash flow to debt ratio of -114.22% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Treace Medical Concepts, Inc.'s free cash flow has increased -39.53% from $-48.76M last year to $-29.49M, signaling increasing performance

Treace Medical Concepts, Inc.'s debt to equity ratio is 1.07, which means that the company's assets are unhealthy financed, signaling financial risk.

Treace Medical Concepts, Inc.'s debt has increased relative to shareholder equity from 0.62 last year to 1.07 today, signaling weakened financials

Treace Medical Concepts, Inc. has a net cash position, so leverage is healthy.

Treace Medical Concepts, Inc.'s interest coverage ratio is -9.23, which means that the company struggles to meet interest obligations, signaling financial risk.

Treace Medical Concepts, Inc.'s profit margin has decreased (8.87%) in the last year from -26.63% to -28.99%, signaling decreasing performance

Treace Medical Concepts, Inc.'s short-term assets of $132.05M exceed its short-term liabilities of $30.64M

Treace Medical Concepts, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Treace Medical Concepts, Inc.'s return on equity of -74.06%, is lower than 15.00%, indicating bad performance

Treace Medical Concepts, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Treace Medical Concepts, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Treace Medical Concepts, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Treace Medical Concepts, Inc. has negative free cash flow, indicating cash burn

Treace Medical Concepts, Inc.'s yearly earnings has decreased 5.85% since last year from $-55.74M to $-59.00M, signaling decreasing performance

Treace Medical Concepts, Inc.'s yearly revenue has increased 1.59% since last year from $209.36M to $212.69M, signaling increasing performance

ROIC -37.54% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Treace Medical Concepts, Inc.'s 3-year revenue CAGR of 14.46% is positive, indicating growing revenue over the past 3 years

Treace Medical Concepts, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Treace Medical Concepts, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Treace Medical Concepts, Inc. has insufficient data to evaluate this check.

Treace Medical Concepts, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Treace Medical Concepts, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Treace Medical Concepts, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Treace Medical Concepts, Inc. has insufficient data to evaluate this check.

Treace Medical Concepts, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Treace Medical Concepts, Inc. has a price-to-book ratio of 4.48x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Treace Medical Concepts, Inc. has a price-to-sales ratio of 1.48x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue